| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Phenobarbital sodium |
Is a |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Phenobarbital measurement |
Component |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbitone blood measurement |
Component |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
2 |
| Serum phenobarbitone measurement |
Component |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
2 |
| Accidental phenobarbitone poisoning |
Causative agent |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Intentional phenobarbitone poisoning (disorder) |
Causative agent |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| forgiftning med phenobarbiton, uvist med hvilken hensigt |
Causative agent |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbitone adverse reaction |
Causative agent |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Allergy to phenobarbital |
Causative agent |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Phenobarbitone overdose |
Causative agent |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Accidental phenobarbitone overdose |
Causative agent |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Intentional phenobarbitone overdose |
Causative agent |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| overdosis af phenobarbiton, uvist med hvilken hensigt |
Causative agent |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 200 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 15 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 30 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 60 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 65 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| phenobarbitalnatrium 130 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Phenobarbital 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Phenobarbital 16.2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Phenobarbital 90 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Phenobarbital 16 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| phenobarbital 20 mg/5 ml eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Oral phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Parenteral phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| belladonna-alkaloider 0,2 mg + ergotamintartrat 0,6 mg + phenobarbital 40 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Product containing phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Poisoning by phenobarbital |
Causative agent |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| belladonna-alkaloider + ergotamintartrat + phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Phenobarbital-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing belladonna alkaloid and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Intentional phenobarbitone poisoning (disorder) |
Causative agent |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Measurement of phenobarbital in urine (procedure) |
Component |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
2 |
| Accidental poisoning by phenobarbitone |
Causative agent |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Allergy to phenobarbital |
Causative agent |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| A teratologic disorder associated with intrauterine exposure of phenobarbital during the first trimester of pregnancy. Infants are usually asymptomatic but an increased risk of intellectual disability, tetralogy of Fallot, unilateral cleft lip, hypoplasia of the mitral valve and some other mild abnormalities such as hypertelorism, epicanthus, hypoplasia and low insertion of the nose, low insertion of the ears, prognathism, finger hypoplasia, brachydactyly and hypospadias have been reported in rare cases. |
Causative agent |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 15 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 60 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 16 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 16.2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 16.2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 90 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 90 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 16 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 16 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
3 |
| Phenobarbital sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
|
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenobarbital (substance) |
Inferred relationship |
Some |
3 |
| Product containing belladonna alkaloid and ergotamine and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 15 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 30 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 60 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 16 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 16.2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 90 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbital 16 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing only belladonna alkaloid and ergotamine and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Belladonna alkaloid and phenobarbital only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing only phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing only phenobarbital in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing only phenobarbital in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 4 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 4 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Serum phenobarbitone measurement |
Component |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Measurement of phenobarbital in urine (procedure) |
Component |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
| Phenobarbitone blood measurement |
Component |
True |
Phenobarbital (substance) |
Inferred relationship |
Some |
1 |
FHIR